The global vaccination drive against severe acute respiratory syndrome coronavirus-2 is
being pursued at a historic pace. Unexpected adverse effects have been reported following …

Glaucoma is one of the most common causes of blindness, thus seriously affecting people's
health and quality of life. The topical medical therapy is as the first line treatment in the …

NO operates throughout the brain as an intercellular messenger, initiating its varied
physiological effects by activating specialized GC‐coupled receptors, resulting in the …

Nitric oxide (NO) is a promising approach for treating ocular hypertension and glaucoma.
However, its clinical application is limited by its uncontrollable release and the unwanted …

Myocilin is highly expressed in the trabecular meshwork (TM), which plays an important role
in the regulation of intraocular pressure (IOP). Myocilin abnormalities may cause dysfunction …

Primary Open Angle Glaucoma (POAG) is the most common form of glaucoma that leads to
irreversible vision loss. Dysfunction of trabecular meshwork (TM) tissue, a major regulator of …

Purpose: Glaucoma, a leading cause of blindness worldwide, often remains undetected until
irreversible vision loss has occurred. Treatments focus on lowering intraocular pressure …

This study developed a dual-responsive in situ gel of nebivolol (NEB), a selective β-
adrenergic antagonist. The gel could achieve sustained concentrations in the aqueous …

Glaucoma, a leading cause of irreversible blindness worldwide, is a spectrum of
neurodegenerative diseases characterized by the gradual deterioration of retinal ganglion …

High intraocular pressure (IOP) has been regarded as a predominant risk factor for
glaucoma. Nitric oxide (NO) is shown to lower IOP, but the magnitude and duration of IOP …